Filteren op Last updated date SelectNaVoorFrom - To Date Einddatum Deze week Deze maand Afgelopen week Afgelopen maand Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Laat dit veld leeg Filter Resultaten (3839) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Laat dit veld leeg Call for patient organisation representatives to join the Committee for Orphan Medicines 4 december 2017NewsCorporateMedicines Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 November 2017 1 december 2017NewsHumanPharmacovigilance Regulatory guidance for pharmaceutical companies to prepare for UK's withdrawal from EU 1 december 2017NewsCorporate Procedural guidance to help pharma companies prepare for Brexit 28 november 2017NewsCorporateBrexit ENCePP: 10 years for excellence in medicines safety 24 november 2017NewsCorporate EU Ombudsman confirms EMA's correct handling of declared interests 24 november 2017NewsCorporate New guidelines on good manufacturing practices for advanced therapies 24 november 2017NewsCorporateCompliance and inspectionsRegulatory and procedural guidance New EudraVigilance system is live 22 november 2017NewsCorporate EMA to relocate to Amsterdam, the Netherlands 20 november 2017Press releaseCorporate Towards a single development programme for new antibiotics in EU, Japan and US 17 november 2017NewsCorporate 1 … 130 131 132 133 134 Page 134 of 384 135 136 137 138 … 384
Call for patient organisation representatives to join the Committee for Orphan Medicines 4 december 2017NewsCorporateMedicines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 November 2017 1 december 2017NewsHumanPharmacovigilance
Regulatory guidance for pharmaceutical companies to prepare for UK's withdrawal from EU 1 december 2017NewsCorporate
New guidelines on good manufacturing practices for advanced therapies 24 november 2017NewsCorporateCompliance and inspectionsRegulatory and procedural guidance
Towards a single development programme for new antibiotics in EU, Japan and US 17 november 2017NewsCorporate